MCI-030

N/A

Report date: 2023/04/25 09:12:30
NME

Base Information

Drug NameMCI-030
Drug Alias NameMCI-030
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesADT Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A